Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND – News) and Metabasis Therapeutics, Inc. (NASDAQ: MBRX – News) announced today they have entered into a definitive merger agreement under which Ligand will acquire all of the outstanding shares of Metabasis.
Under the transaction, Metabasis stockholders will receive a cash payment [...]
NanoString Technologies announced the first peer-reviewed publication describing NanoString’s technology will be published in the Nature Biotechnology March 7th issue and is available in the Advanced Online Publication section.
The paper entitled Direct Multiplexed Measurement of Gene Expression with Color-Coded Probe Pairs describes the performance of the nCounter Analysis System, which captures and counts individual mRNA [...]
The biotechnology industry, which for years has opposed bills that would allow FDA to approve generic versions of biotech medications, has made such legislation a priority for 2008, the AP/Raleigh News & Observer reports. Several bills currently under consideration in Congress would allow FDA to approve generic versions of biotech medications, and the Bush administration [...]
Cougar Biotechnology, Inc. (NASDAQ:CGRB) announced that results from ongoing Phase I and Phase II clinical trials of Cougar’s investigational drug, CB7630 (abiraterone acetate), were presented at the ASCO Genitourinary Cancers Symposium that is currently taking place in San Francisco, California. The data was presented today in both an oral presentation and two poster presentations. These [...]
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
| By N2H | |||||||||||||